ANDA 71879, held by Watson Labs. Clorazepate Dipotassium.
As of Nov 15, 2026, ANDA 71879 (Clorazepate Dipotassium), held by Watson Labs, was first approved by FDA on Jun 28, 1989, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 28, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clorazepate Dipotassium7.5MG ยท capsule;oral | Clorazepate Dipotassium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
